[HTML][HTML] Oral candidiasis: A disease of opportunity
T Vila, AS Sultan, D Montelongo-Jauregui… - Journal of fungi, 2020 - mdpi.com
Oral candidiasis, commonly referred to as “thrush,” is an opportunistic fungal infection that
commonly affects the oral mucosa. The main causative agent, Candida albicans, is a highly …
commonly affects the oral mucosa. The main causative agent, Candida albicans, is a highly …
Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action
Biofilm refers to the complex, sessile communities of microbes found either attached to a
surface or buried firmly in an extracellular matrix as aggregates. The biofilm matrix …
surface or buried firmly in an extracellular matrix as aggregates. The biofilm matrix …
[HTML][HTML] Candida Biofilms: Threats, Challenges, and Promising Strategies
M Cavalheiro, MC Teixeira - Frontiers in medicine, 2018 - frontiersin.org
Candida species are fungal pathogens known for their ability to cause superficial and
systemic infections in the human host. These pathogens are able to persist inside the host …
systemic infections in the human host. These pathogens are able to persist inside the host …
Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …
patients. They are not intended to supplant physician judgment with respect to particular …
Antifungals
S Campoy, JL Adrio - Biochemical pharmacology, 2017 - Elsevier
The need for new antifungal agents is undeniable. Current therapeutic choices for the
treatment of invasive fungal infections are limited to three classes of drugs. Most used …
treatment of invasive fungal infections are limited to three classes of drugs. Most used …
[HTML][HTML] Antifungal therapy: new advances in the understanding and treatment of mycosis
L Scorzoni, ACA de Paula e Silva, CM Marcos… - Frontiers in …, 2017 - frontiersin.org
The high rates of morbidity and mortality caused by fungal infections are associated with the
current limited antifungal arsenal and the high toxicity of the compounds. Additionally …
current limited antifungal arsenal and the high toxicity of the compounds. Additionally …
Pathogenesis of Candida albicans biofilm
C Tsui, EF Kong, MA Jabra-Rizk - FEMS Pathogens and …, 2016 - academic.oup.com
Candida albicans is the most common human fungal pathogen causing diseases ranging
from mucosal to systemic infections. As a commensal, C. albicans asymptomatically …
from mucosal to systemic infections. As a commensal, C. albicans asymptomatically …
Candida parapsilosis: from genes to the bedside
R Tóth, J Nosek, HM Mora-Montes… - Clinical microbiology …, 2019 - Am Soc Microbiol
Patients with suppressed immunity are at the highest risk for hospital-acquired infections.
Among these, invasive candidiasis is the most prevalent systemic fungal nosocomial …
Among these, invasive candidiasis is the most prevalent systemic fungal nosocomial …
The emerging pathogen Candida auris: growth phenotype, virulence factors, activity of antifungals, and effect of SCY-078, a novel glucan synthesis inhibitor, on …
E Larkin, C Hager, J Chandra… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Candida auris, a new multidrug-resistant Candida spp. which is associated with invasive
infection and high rates of mortality, has recently emerged. Here, we determined the …
infection and high rates of mortality, has recently emerged. Here, we determined the …
Candida albicans biofilm growth and dispersal: contributions to pathogenesis
G Wall, D Montelongo-Jauregui, BV Bonifacio… - Current opinion in …, 2019 - Elsevier
Highlights•Biofilm formation is a major contributor to pathogenesis during Candida
infection.•C. albicans biofilm formation is a multi-step, highly regulated process.•Cells in …
infection.•C. albicans biofilm formation is a multi-step, highly regulated process.•Cells in …